Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rocket man..
This is a MAJOR endorsement of Aurinia:
— Mikey Likes It (@TheMach99) August 19, 2021
BRometer. Must say, I really like it. Clever girl - from scene of Jurassic Park
SRNE is all fake. It is just PR..
Market is smarter than what Peter did. Those two assets have zero value at this point as they are not even in the clinic. Ten years out, minimum..
To be deleted I’m told…
Want na bet?
I expect they called Francois’ bluff…
Makes no sense..
Peter Greenleaf would take $25 in a heartbeat.. No offers near there..
No buyout now, they are going it alone..
Jess, it is gratifying to see you are using accredited websites for your investment research. Nothing beats Stonkmoon.com
https://www.stonkmoon.com/news/AUPH/3b03308b1f39faacadfb16a0dfc02507
8^)
The stock was done, not me.!
Nope. Bought back after the meltdown
This is really bad. China does it again.
This is the opening that China was looking for:
China doubles down on smart vehicle data regulation after Tesla’s EV recall
The MIIT has proposed new regulations covering management of smart connected vehicles and control of the vast amount of data these cars generate
Connected vehicle makers such as Tesla must also provide clear information about their cars’ automated driving assistance and other autopilot capabilities
https://www.scmp.com/tech/policy/article/3144811/china-doubles-down-smart-vehicle-data-regulation-after-teslas-ev-recall?utm_source=copy_link&utm_medium=share_widget&utm_campaign=3144811
Some of those calls were the ones I sold. The premiums are Ridiculously high. Book the premium dude. Sure, I will give up some upside, but in this market, nothing is safe..
Down $.45 for the day, and another $.29 after hours. Down $.75 today. Is that because Neil, the CSO, sold a HUGE chunk of his holdings??,
No. Anything can happen with small cap biotech
They get it now. Up another $1.13 as I type
Target raised to $29 at DB..
This really changes everything.. Max is a stud. It is all his doing.. Create a pile of options for this genius…
Francois only buys the originals!
Oh I like this link:
Lupky in the Sky with Diamonds!!
They crushed it! $6.6 million. Back on track..
It is funny how the Motley Fool has latched on to Aurina like a pit bull and will not let go. There is a person on Twitter that works for the firm and has a significant stake in Aurina..
Cosa, many of those calls were written for premium income. We want those to expire worthless..
I doubt that. Cramer’s remarks were neutral so it seems. I expect there has been a leak of the sales. Yes, a leaker..for Q2.
This has been so reliable in predicting Covid surge in cities, yet it hasn’t become a standard. Puzzling..
Wastewater readings tell you when to duck and cover. In Boston, that would be now. The rise reflects virus shed into the sewer and precedes diagnosed case rise by a few days. https://t.co/ibGNEIrjR6
— Antonio Regalado (@antonioregalado) August 4, 2021
What is everyone’s guess on Q2 sales? $2-$4 million??
Rum, I sold a bunch, but just wished I sold more of those $20 calls. They were really elevated in price for being so far out-of-the-money.. I kept hearing from the perma bulls here and thought maybe I should hold off….what was I thinking….
Rolex’s for everyone
Down $1 today? And the week is early..
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
PUBLISHED
2 August 2021
2 August 2021 07:00 BST
Saphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosus
I think this will be big in SLE. Remember, if you can suppress SLE, LN cases will be Drastically reduced..
Jess, I’ll be kind to you because you are a loyal poster here, but do you really think I would still be here posting if I didn’t have some skin in the game?? There is no one on this board that would dare short this with the knowledge we have gained from being here. This is purely entertainment as it should be. I know some take it too seriously….. It is only money…
Looks like I should have sold the whole lot, damit…..
They whole point is the uptake of the drug. That is THE only thing that matters. Remember, they have been treating this disease with a plethora of drugs over many years. Will they pay the BIG BUCKS to switch? I sure hope so, but I’m hedging my bet…
$AUPH ‘Thar she blows!!!! pic.twitter.com/iJhspbwZ3y
— DJ (@blue_mead) July 30, 2021
How did I do? With a 25% move in Auphie with no verifiable news, you just got to take some off the table, or sell pumped up $20 covered calls..
You’ve lost money then. Biotech merger activity has been a dog compared to other years.
Lack of deals. Plural. Maybe you don’t follow the biotech space closely, but there has been very few biotech takeover‘s over the last 12 months. And that’s what everyone’s waiting for.